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Summary
Objective: To investigate leptin’s effect on cartilage metabolism and the pathophysiology of osteoarthritis (OA).
Methods: Messenger RNA (mRNA) expression and protein levels of leptin and leptin’s receptor isoforms were measured by real-time reverse
transcription-PCR and Western blot in osteoarthritic and normal cartilage. Osteoarthritic cartilage samples were obtained from two locations
of the knee (n¼ 11) and hip (n¼ 6); from the main defective area (advanced OA) and from adjacent macroscopically and histological intact
regions (minimal OA). Paired serum and synovial ﬂuid (SF) leptin levels were measured. The effect of leptin was evaluated on chondrocyte
proliferation, IL-1b (interleukin-1b), NO and metalloproteinases 9 and 13 (MMP-9, MMP-13) protein expression.
Results: Leptin’s and leptin’s receptor (Ob-Rb) expression levels were signiﬁcantly increased in advanced OA cartilage compared to minimal.
Leptin was signiﬁcantly increased in SF than serum samples. Also, leptin had a detrimental effect on chondrocyte proliferation and induced
IL-1b production and MMP-9 and MMP-13 protein expression. Furthermore, leptin’s mRNA expression in advanced OA cartilage was
signiﬁcantly correlated with BMI of the patients.
Conclusion: The increased leptin levels in SF point toward a local effect of leptin in articular cartilage, while the observed intrajoint differences
of leptin and Ob-Rb mRNA expression may be related to the grade of cartilage destruction. The observed production of IL-1b, MMP-9 and
MMP-13 by chondrocytes after leptin treatment indicates a pro-inﬂammatory and catabolic role of leptin on cartilage metabolism. Furthermore,
the observed correlation of leptin’s mRNA expression with BMI suggests that leptin may be a metabolic link between obesity and OA.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.





Leptin, the 16 kDa non-glycosylated protein product of the
obese (ob) gene, is a cytokine-like hormone secreted mainly
by white adipose tissue1. It inﬂuences body weight homeo-
stasis through its effects on food intake and energy expendi-
ture by negative feedback at the hypothalamic nuclei, while it
is also produced by nonadipocytic cells and targets in ex-
trahypothalamic tissues2,3. Leptin is a pleiotropic hormone,
implicated as a regulatory molecule in various physiologic
processes, such as lipid metabolism, hemopoiesis, immune
system modulation, angiogenesis, ovarian function, repro-
duction and inﬂammation4e9. Recently, it has been found
that leptin acts as a regulator of bone growth inducing osteo-
blast proliferation, collagen synthesis and bone mineraliza-
tion and also stimulating endochondral ossiﬁcation10e14.
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Received 6 April 2006; revision accepted 23 January 2007.87The biological activity of leptin is mediated by speciﬁc re-
ceptors (Ob-R) which belong to class I cytokine receptors
and are products of the db gene transcript15. In humans,
there exist at least ﬁve isoforms of leptin receptor, gener-
ated by messenger RNA (mRNA) alternative splicing, which
are membrane-spanning glycoproteins with cytoplasmic
domains of ranging length16,17. The long isoform of leptin
receptor (Ob-Rb) contains the intracellular motifs required
for the activation of the JAK/STAT (Janus kinase/signal
transducer and activator of transcription) signal transduction
pathway. Recently, it has also been suggested that Ob-Rb
besides its signaling in the JAK/STAT pathway, it is capable
to transduce signals by using alternative signaling path-
ways, which link tyrosine phosphorylation events to Renin
Angiotensin System activation, representing probably a crit-
ical step of cell proliferation and differentiation3,17,18. The
shorter isoforms (Ob-Ra, Ob-Rc, Ob-Rd and Ob-Rf) have
truncated cytoplasmic domains with reduced signaling
transduction capabilities16,19,20. Of the short isoforms, Ob-
Ra is the most abundantly expressed and well conserved
among species and has been shown that it has a transport
as well as a clearance role3.2
873Osteoarthritis and Cartilage Vol. 15, No. 8Increasing evidence suggests that leptin is a novel pro-
inﬂammatory adipocyte-derived factor that operates in the
cytokine network by linking immune and inﬂammatory
processes to the neuroendocrine system21. A pro-inﬂam-
matory role of leptin through its receptor Ob-Rb has been
suggested in inﬂammatory conditions as multiple sclerosis,
rheumatoid arthritis, non-alcoholic steatohepatitis, autoim-
mune encephalomyelitis and other diseases, probably by
the induction of pro-inﬂammatory factors as tumor necrosis
factor, interferon (INF-g), interleukin (IL-2), COX-2 and nitric
oxide production22,23. It has been shown that leptin may dis-
play pro- or anti-inﬂammatory effects in the joints depending
on the immune response24,25. Leptin-deﬁcient ob/ob mice
develop resistance to experimental antigen-induced arthritis
in comparison with wild-type mice25. In addition, fasting,
which is associated with decreased circulating leptin levels,
leads to decreased CD4þ lymphocyte activation and
increased IL-4 secretion in patients with rheumatoid
arthritis26. It has also been found that leptin increases the
inﬂammatory effects of pro-inﬂammatory cytokines, as
IFN-g and IL-1, acting in synergy on nitric oxide produc-
tion21,22. Conversely, leptin may stimulate anabolic func-
tions on chondrocytes through the induction of growth
factors synthesis, such as transforming growth factor-b or
insulin growth factor-1, being part of the attempted repair re-
sponse in osteoarthritic cartilage27,28.
The potential role of leptin in osteoarthritis (OA) has been
supported by the relationship between obesity and in-
creased risk of OA development29. This positive association
has been observed not only for weight bearing joints, such
as knees, but also for non-weight bearing joints, such as
hands30e32. Further evidence for the involvement of leptin
in OA comes from the observation that leptin has been
found in the synovial ﬂuid (SF) of OA patients and its con-
centration has been correlated with body mass index
(BMI)27. In addition, the functional isoform of leptin’s recep-
tor (Ob-Rb) has been detected in cultured human adult ar-
ticular chondrocytes and leptin treatment of isolated cells
in vitro has been shown to stimulate matrix synthesis33. It
has been suggested that leptin has a local effect on OA car-
tilage, since its levels in the SF have been found to be
higher than those in the serum34.
In the present study to elucidate on leptin’s role in the pro-
cess of OA, we evaluated, for the ﬁrst time to our knowledge,
leptin and leptin receptors (Ob-Rb, Ob-Ra) mRNA and pro-
tein expression in advanced and minimal OA cartilage as
well as in normal articular cartilage. Additionally, leptin’s ef-
fect on cartilage metabolism was investigated by studying
its effect on Ob-Rb mRNA expression, IL-1, NO and for the
ﬁrst time on MMP-9 and MMP-13 production, in normal and
osteoarthritic chondrocyte cultures. Furthermore, to assess
on leptin’s role as a metabolic link between obesity and OA,
leptin’s mRNA expression levels were evaluated in OA carti-
lage from obese and normal weight persons.
Materials and methods
PATIENTS AND CARTILAGE SAMPLES
Articular cartilage samples were obtained from femoral
heads, femoral condyles and tibial plateaus of patients with
primary OA undergoing hip or knee replacement surgery at
the Orthopaedics Department of University Hospital of
Larissa. A total of 17 patients were included in the study (six
males, 11 females; mean age 64.18 14.24 years, range
40e86; mean body mass index (BMI) 28.82 4.21, range
20.28e35.56). Eleven patients (two males, nine females;mean age 71.45 8.56 years, range 58e86; mean BMI
29.43 4.6, range 20.28e35.56) had undergone total knee
replacement surgery and six patients (four males, two fe-
males; mean age 50.83 13.1 years, range 40e70; mean
BMI 27.73 3.48, range 22.04e30.48) total hip replacement
surgery. Two specimenswere taken fromevery patient. Each
sample was categorized according to its gross morphology,
as either severely damaged (advancedOA),whichwas taken
from the main defective area of maximal load, or mildly dam-
aged (minimal OA) taken from areas with no obvious surface
defects. Macroscopic ﬁndings were validated by histological
studies performed on 5 mm serial sections of cartilage sam-
ples and graded using the Mankin score35,36. Specimens
with mild OA had 1e4 Mankin score, while specimens with
advanced OA had Mankin score 10e14 [Fig. 1(aec)].
Normal cartilage was obtained from ﬁve individuals (two
males, three females; mean age 36.6 12.6, range 25e58;
mean BMI 25.04 0.83, range 23.88e25.97) with 0 Mankin
score, undergoing fracture repair surgery, with no history of
joint disease.
Detailed clinical data were obtained from patients and
controls regarding grade of physical activity, BMI, presence
of pain, as well as stiffness and swelling of the joint. Cate-
gories regarding overweight and obesity were constructed
based on a graded classiﬁcation that applies to both men
and women proposed by World Health Organization37: nor-
mal BMI< 25 kg/m2, overweight BMI 25.0e29.9 kg/m2 and
obese BMI 30.0 kg/m2. As the majority of patients were
overweight or obese, levels of obesity were also catego-
rized based to tertiles of BMI.
Radiographs were obtained before surgery and graded
according to the KellgreneLawrence system38,39. The ra-
diographs were assessed by two independent observers
who were blinded to all data of the individuals.
Patients with rheumatoid arthritis and other autoimmune
disease as well as chondrodysplasias, infection-induced
OA and posttraumatic OA were excluded from the study.
The study protocol conformed to the ethical guidelines of
the 1975 Declaration of Helsinki as reﬂected in a priori ap-
proval by the Local Ethical Committee of the University
Hospital of Larissa.
ISOLATION OF RNA FROM HUMAN CARTILAGE
AND CULTURED CHONDROCYTES
Fresh tissue, within 1 h from surgery, was dissected, and
total cellular RNAwas extracted using Trizol reagent (Invitro-
gen, Life Technologies, Paisley, UK). Cultured chondrocytes
were trypsinized, collected and centrifuged for 10 min at
1700 rpm and total cellular RNA was extracted using Trizol
reagent. RNA from human cartilage and cultured chondro-
cytes was further puriﬁed using an RNeasy mini kit (Qiagen,
Hilden, Germany) according to manufacturers’ instructions.
Preservation of 28S and 18S ribosomal RNA (rRNA) species
was used to assessRNA integrity. All the samples included in
the study were with prominent 28S and 18S rRNA compo-
nents. The yield was quantiﬁed spectrophotometrically.
REVERSE TRANSCRIPTION-PCR OF LEPTIN,
OB-RB AND OB-RA MRNA
OnemicrogramofRNAwas reverse transcribed to comple-
mentary DNA (cDNA) using Moloney murine leukemia virus
reverse transcriptase (M-MLV-RT, Invitrogen, Life Technolo-
gies, Paisley, UK) as well as random primers (Gibco, BRL-
UK). As an internal control, the cDNA was subjected to
PCR analysis for the retinoic acid receptor alpha gene
874 T. Simopoulou et al.: Leptin’s expression in OA CartilageFig. 1. (a) Distal femur and tibial plateau of patient undergoing total
knee replacement surgery showing full thickness degeneration of
cartilage in the median femoral condyle (MFC) and relatively nor-
mal appearance of cartilage in the lateral femoral condyle (LFC).
(b) Advanced OA: the articular cartilage contains vertical clefts re-
sulting from fraying and splitting of the collagen ﬁbers at the surface
of the cartilage. There is proliferation of chondrocytes within the
cartilage matrix (Hematoxylin and Eosin stain). (c) Minimal OA: min-
imal disruption of the cartilage surface. Uniform distribution of chon-
drocytes throughout the width and depth of the tissue (Hematoxylin
and Eosin stain).(RARa). PCR primers were selected to amplify a 499 base
pairs (bp) fragment for leptin (forward 50-GCATTGGGGAA
CCCTGTG-30; reverse 50-AGCACCCAGGGCTGAGGT-30),
a 501 bp fragment for Ob-Rb (forward 50-GCTATTTTGG
GAAGATGT-30; reverse 50-TGCCTGGGCCTCTATCTC-30)
and a 394 bp fragment for Ob-Ra (forward 50-TGTTGTGA
ATGTCTTGTGCC-30; reverse 50-TGCTCCAGTCACTCCA
GATTCC-30). For leptin reverse transcription-PCR (RT-
PCR) experiments 0.5 ml Taq polymerase (Gibco, BRL-UK),
1 ml deoxy-nucleotide triphosphates, 1.5 ml MgCl2 and 1 ml
of the speciﬁc primers, along with 10 ml cDNA, were used;
while for Ob-Rb and Ob-Ra 2 ml of the speciﬁc primers was
used. The thermal cycling conditions for leptin and Ob-Rb in-
cluded 58C as annealing temperature for 35 cycles and 40
cycles, respectively, while for Ob-Ra 57Cannealing temper-
ature for 30 cycles. The PCR products were separated on
a 3% agarose gel and were visualized with ethidium bromide
staining. A 100-bpDNA ladder (Gibco-BRL, UK)was used as
molecular weight standard.
REAL-TIME, QUANTITATIVE RT-PCR OF LEPTIN,
OB-RB AND OB-RA MRNA
Theoretically, real-time quantitative PCR monitors the
degradation of a sequence-speciﬁc, dual-labeled ﬂuores-
cent probe after each cycle of PCR ampliﬁcation. Transcrip-
tion of 0.1 mg RNA to cDNA was performed using the AMV
Kit (Roche, IN, USA). RARa cDNA sequences were
ampliﬁed in separate reactions as positive cDNA controls.
LightCycler Primer set (Roche, IN, USA) was used for the
primers for porphobilinogen deaminase (PBGD) as a house-
keeping gene. Standard PBGD cDNAs with known copy
numbers were included in the LightCycler Primer set. Quan-
tiﬁcation was performed by real-time PCR (LightCycler
Instrument, Roche Molecular Systems, Alameda, CA) in
0.2 ml of cDNA for each analyzed sample using the LightCy-
cler FastStart DNA Master HybProbe Kit (Roche, Penzberg,
Germany) according to manufacturers’ instructions. The
oligonucleotide primers used for Ob-Rb were 50-GCTATTT
TGGGAAGATGT-30 (forward, 288e306 in exon 19) and
50-TGCCTGGGCCTCTATCTC-30 (reverse, 553e570 in
exon 20), for Ob-Ra were 50-TGTTGTGAATGTCTTGT
GCC-30 (forward, 402e421 in exon 6) and 50-TGCTCCAG
TCACTCCAGATTCC-30 (reverse, 649e668 in exon 8)
and for leptin were 50-TTCTTGTGGCTTTGGCCCTA-30
(forward, 81e100 in exon 2) and 50-GGAGACTGAC
TGCGTGTGTGTGAA-30 (reverse, 191e212 in exon 2).
Temperature cycles were as follows: 95C for 10 min fol-
lowed by 45 cycles at 95C for 5 s, 55C for 10 s, 72C
for 10 s for leptin, 47 cycles at 95C for 10 s, 58C for
10 s, 72C for 10 s for Ob-Rb and 45 cycles at 95C for
10 s, 57C for 10 s, 72C for 10 s for Ob-Ra. Cooling was
performed at 40C for 30 s for all genes. The PCR products
were separated on 2% agarose gel and were visualized
with ethidium bromide staining, in order to certify the exis-
tence of only one amplicon. Determination of the speciﬁc
PCR products was done by direct sequencing. The ex-
pected PCR products were 132 bp for leptin, 501 bp for
the Ob-Rb and 394 bp for the Ob-Ra. A standard curve
was created using serial dilutions of the mRNA obtained
from adipose tissue. All samples were analyzed in duplicate
and the average value of the duplicates was used for quan-
tiﬁcation. The variation in the two measurements for each
sample was generally in a range of 0.1% to approximately
10%. If the variation of a sample exceeded 10%, a novel
triplicate assay was carried out for this sample. The data
were expressed as the ratio of the levels of the target
875Osteoarthritis and Cartilage Vol. 15, No. 8gene mRNA on that of the housekeeping gene PBGD (lep-
tin or Ob-Rb or Ob-Ra mRNA copies/PBGD copies), which
was used as an internal control.
LEPTIN AND OB-R PROTEIN EXPRESSION
ON CHONDROCYTES
Protein extraction
OA and normal chondrocytes were trypsinised, collected
and centrifuged for 10 min at 1700 rpm. The cell pellet was
washed with PBS and then centrifuged as previously. The
cell pellet was lysed using Nonidet P-40 lysis buffer contain-
ing 30 mM Tris (pH 7.5), 150 mM NaCl, 10% glycerol, 1%
Nonidet P-40, and a cocktail of protease inhibitors for
30 min on ice, followed by centrifugation for 15 min at
12,000 rpm. The supernatant was transferred in another
tube and stored at20C. Protein concentration was quanti-
ﬁed using the Bio-Rad Bradford protein assay (Bio-Rad,
Hercules, CA) with bovine serum albumen as standard.
Western blot analysis
Cell lysates from normal and OA chondrocytes were elec-
trophoresed and separated on a 10%TriseHCl gel (Bio-Rad,
Hercules, CA) and transferred to a Hybond-ECL nitrocellu-
lose membrane (Amersham Biosciences, Piscataway, NJ).
The membrane was probed with anti-leptin (1:2000 dilution)
(Sigma, St Louis,MO) or anti-Ob-Rb (1:300) (SantaCruzBio-
technology, Santa Cruz, CA) and signals were detected us-
ing anti-rabbit immunoglobulin IgG conjugated with
horseradish peroxidase (1:5000 dilution). The nitrocellulose
membranes were then exposed to photographic ﬁlm, which
was scanned and the intensities of the protein bands, which
were expressed as arbitrary units, were determined by com-
puterized densitometry.
QUANTIFICATION OF WESTERN BLOT
Leptin protein levels were normalized to glyceraldehyde-
3-phosphate dihydrogenase (GAPDH) protein levels. Protein
expression levels of Western blots were quantiﬁed using the
Image Quant 6 program analysis. Image Quant uses a
process called quantitation to compare the relative darkness
of different bands on the scanned image of a gel. Volume in-
tegration method was used in order to evaluate the relative
density of bands in different lanes. The numerical value of
each pixel within a prescribed area is added together. The
total represents the amount of the sample contained within
the prescribed area. A portion of that total is attributable to
backgroundmaterial and should be subtracted so that the ac-
tual amount of the sample will be represented in the analysis
of the bands being compared.
PRIMARY CULTURES OF NORMAL AND OSTEOARTHRITIC
HUMAN ARTICULAR CHONDROCYTES
Articular cartilage from all patients was transported from the
surgical room in hanks balancedsalt solution (HBSS)medium,
was immediately dissected and subjected to sequential diges-
tion with 1 mg/ml pronase (Roche Applied Science, Germany)
for 90 min and 1 mg/ml collagenase P (Roche Applied Sci-
ence, Germany) for 3 h at 37C. Chondrocytes were counted
and checked for viability using trypan blue staining. More
than 95%of the cells were viable after isolation. Chondrocytes
were then seeded in six-well plates with Dulbecco’s Modiﬁed
Eagles Medium/Ham’s F-12 (Gibco-BRL, UK) plus 5% fetalbovine serum and 100 U/ml penicillinestreptomycin and
were incubated at 37C under a humidiﬁed 5% CO2 atmo-
sphere.After reachingconﬂuence, cellswerecultured inserum
deprived medium for 24 h and were subsequently stimulated
with leptin (0e100 ng/ml) up to 7 days. RNA was extracted
with the above mentioned procedure and experiments on
Ob-Rb and Ob-Ra mRNA expression were conducted.
MEASUREMENT OF IL-1b AND NO IN
CELL CULTURE SUPERNATES
Normal and osteoarthritic chondrocytes were stimulated
with leptin for 24 h, 48 h, 72 h as well as 7 days and cell cul-
ture supernates were removed, centrifuged and stored at
80C until assayed. IL-1b and NO were measured using
commercially available assays according to manufacturer’s
instructions (R & D Systems, MN, USA). For IL-1b, the intra-
and inter-assay coefﬁcients of variation were 2.85% and
4.86%, respectively, and the detection limit of the kit was
1 pg/ml. The assay for NO was based on the enzymatic
conversion of nitrate to nitrite by nitrate reductase, followed
by colorimetric detection of nitrite as an azo dye product of
the Griess Reaction, while the intra- and inter-assay coefﬁ-
cients of variation were 1.83% and 3.86%, respectively, and
the mean minimum detectable dose was 0.25 mmol/l. Sam-
ples were assayed in duplicate, after a 10-fold dilution with
solution supplied by the manufacturer.
MMP-9 AND MMP-13 PROTEIN EXPRESSION
AFTER LEPTIN TREATMENT
Normal and osteoarthritic chondrocytes were seeded in 12
well plates (105 cells/ml)with 400 ml of serumdeprivedmedia,
incubated for 48 h and then treated with different leptin con-
centrations (0e100 ng/ml). The cells were collected 5 and 7
days after leptin treatment and protein extraction, Western
blot analysis and quantiﬁcation of Western blot for MMP-9
and -13 were performed as described above for leptin.
MTT ASSAY
Chondrocyte proliferation was assessed in the presence
of increasing concentrations of leptin (0e100 ng/ml) (R&D
systems, MN, USA), by the use of an MTT assay (3-[4,5-
dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide) (R &
D Systems, MN, USA). Cell proliferation was examined at
24 h, 48 h, 72 h and 7 days after addition of leptin.
FLOW CYTOMETRIC ANALYSIS OF APOPTOSIS
A ﬂow cytometry apoptosis detection kit (Annexin V-FITC/
7-AAD [7-aminoactinomycin] kit, Beckman Coulter, France)
was used to identify programmed cell death. Cells were
suspended in 100 ml of Annexin V binding buffer and were
then stained with 10 ml ﬂuorescein isothiocyanate-labeled
annexin V (to detect phosphatidylserine expression on cells
during early apoptotic phases) and 7-AAD (to exclude dead
cells) in the dark. Flow cytometry was performed using the
EPICS XL-MCL Counter (Beckman Coulter, USA) and anal-
ysis of the data was made using CellQuest data acquisition
and analysis software. Data were acquired from at least
10,000 events.
LEPTIN’S DETERMINATION IN SERUM AND SF
Venous blood samples were taken from all patients before
surgery after 12 h fasting and serum samples were stored at
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placed on ice and centrifuged at 3000 g for 30 min. Superna-
tant was separated and stored at 80C until analysis for no
longer than threeweeks. Leptin concentrationwasmeasured
using a commercially available assay that employs a quanti-
tative sandwich enzyme immunoassay technique, according
to manufacturer’s instructions (R&D Systems, MN, USA). Di-
lution experiments were performed to validate the use of
a commercially available enzyme-linked immunosorbent as-
say kit for SF samples. Samples weremeasured in duplicate.
The intra- and inter-assay coefﬁcients of variation were
3.16% and 4.36%, respectively, and the detection limit of
the kit was 7.8 pg/ml.
STATISTICAL ANALYSIS
All calculations were performed using the SPSS software
(version 11.0). Data were analyzed by unpaired t test, the
paired t test, as well as analysis of variance (ANOVA) and
the Tukey’s Honestly Signiﬁcant Different (HSD) test as the
post hoc test, where applicable. Correlation coefﬁcients
werecalculatedbyPearson rankcorrelation (r) andSpearman
rank correlation where applicable. Comparisons of the levels
between matched pairs of SF and serum samples were
made by the Wilcoxon signed rank test. A two-sided P value
less than 0.05 was considered as statistically signiﬁcant.
Results
PATIENT DATA
All patients suffered from load or even rest-pain of the
affected joint. Patients with knee OA had temporary or
permanent swelling of the joint. We observed a female pre-
dominance (female/male: 9/2), as well as signiﬁcantly older
age in knee OA group (P< 0.001). Knee OA patients had
signiﬁcantly higher incidence of hypertension, as expected
due to their older age. Regarding the BMI of the patients no
signiﬁcant differences were found between knee and hip
OA. In our study, controls had a zero (0) Kellgrene
Lawrence (K/L) score and all patients had a K/L score> 2.
No signiﬁcant correlation was found between the K/L score
and other clinical data of the patients (pain, swelling, stiff-
ness, history of hypertension and osteoporosis).
LEPTIN, OB-RB AND OB-RA MRNA EXPRESSION
BY CONVENTIONAL RT-PCR
Human adult articular chondrocytes derived from ad-
vanced osteoarthritic cartilage expressed leptin as well as
the two leptin receptor isoforms, the long (Ob-Rb) and the
short isoform (Ob-Ra), as detected by RT-PCR. Chondro-
cytes isolated from minimal osteoarthritic cartilage, as well
as from normal joints, expressed only the short isoform of
leptin’s receptor (Ob-Ra) (Fig. 2). Cultured normal and oste-
oarthritic chondrocytes expressed leptin as well as Ob-Rb
and Ob-Ra mRNA.
LEPTIN, OB-RB AND OB-RA MRNA EXPRESSION
BY REAL-TIME QUANTITATIVE RT-PCR
Using quantitative real-time PCR we conﬁrmed our
RT-PCR ﬁndings and furthermore we observed leptin and
Ob-Rb mRNA expression in normal articular cartilage and
in minimal osteoarthritic cartilage, even though at low levels.
Overall, leptin was expressed at signiﬁcantly higher levels in
osteoarthritic compared to normal cartilage (P< 0.001).Whenwe grouped our patients according to the osteoarthritic
joint (hip or knee), we did not observe any signiﬁcant differ-
ence in leptin mRNA expression levels between the two
joints. Since specimens with mild and severe damaged OA
cartilage have been collected in the same joint, statistical
analysis with matched pairs of samples was performed.
There was a statistically signiﬁcant increase in leptin
mRNA expression from the mild (0.064 0.068 leptin cop-
ies/PBGD copies) to the severely (0.20 0.093 leptin cop-
ies/PBGD copies) damaged OA cartilage (t(15)¼ 6.798,
P< 0.0001). When we grouped our patients according to
the affected joint, we observed a similar increase in leptin’s
mRNA expression form mild to severe affected OA cartilage.
More speciﬁcally, for knees a signiﬁcant increase in leptin’s
mRNA expression was observed from mild (0.093 0.066
leptin copies/PBGD copies) to severe (0.232 0.092 leptin
copies/PBGD copies) OA affected cartilage (t(9)¼ 5.649,
P< 0.001). Similarly for hips, a signiﬁcant increase in leptin’s
mRNA expression was observed from mild (0.015 0.037
leptin copies/PBGD copies) to severe (0.153 0.076 leptin
copies/PBGD copies) OA affected cartilage (t(5)¼ 3.553,
P< 0.016) [Fig. 3(a)]. Both in knees and hip OA joints no sig-
niﬁcant differences were found in leptin mRNA expression
between normal and minimal OA cartilage.
Regarding the Ob-Rb mRNA expression levels, we de-
tected Ob-Rb mRNA expression in OA cartilage as well as
in normal cartilage. We observed higher mRNA expression
levels in advanced OA cartilage compared to minimal OA
(P< 0.001). When matched paired analysis of the samples
was performed a statistically signiﬁcant increase (t (15)¼
4.154, P< 0.001) was observed from the mild (0.018
0.030 Ob-Rb copies/PBGD copies) to severe damaged OA
cartilage (0.212 0.183 Ob-Rb copies/PBGD copies). In
the knees, we observed a statistically signiﬁcant increase
in Ob-Rb mRNA expression from mild (0.01 0.015 Ob-
Rb copies/PBGD copies) to severe (0.26 0.21 Ob-Rb
copies/PBGD copies) OA affected cartilage (t(9)¼ 3.766,
P< 0.004). For hips, there was a signiﬁcant difference in
Ob-Rb mRNA expression from mild (0.030 0.044 Ob-Rb
Fig. 2. Representative gel showing leptin (499 bp), Ob-Ra (394 bp)
and Ob-Rb (501 bp) (a) and internal control RARa (b) mRNA ex-
pression in normal, advanced OA and minimal OA cartilage. Lane
1: marker 100 bp ladder, lane 2: leptin in minimal OA cartilage,
lane 3: Ob-Ra in minimal OA cartilage, lane 4: Ob-Rb in minimal
OA cartilage, lane 5: leptin in advanced OA cartilage, lane 6: Ob-
Ra in advanced OA cartilage, lane 7: Ob-Rb in advanced OA car-
tilage, lane 8: leptin in normal cartilage, lane 9: Ob-Ra in normal
cartilage, lane 10: Ob-Rb in normal cartilage.
877Osteoarthritis and Cartilage Vol. 15, No. 8Fig. 3. (a) Comparison of the mean leptin’s mRNA expression levels (leptin mRNA copies/PBGD copies) in knees and hips of all patients
between mild and advanced OA. Data are shown as mean standard error. (*) P< 0.001 and (#) P< 0.016 were considered signiﬁcant.
(b) Comparison of the mean Ob-Rb’s mRNA expression levels (Ob-Rb mRNA copies/PBGD copies) in knees and hips of all patients between
mild and advanced OA. Data are shown as mean standard error. (*) P< 0.004 and (#) P< 0.05 were considered signiﬁcant.copies/PBGD copies) to severe (0.132 0.089 Ob-Rb cop-
ies/PBGD copies) OA affected cartilage (t(5)¼ 2.588,
P< 0.05) [Fig. 3(b)]. No signiﬁcant differences in Ob-Rb
mRNA expression were observed between hip and knee
joints (P> 0.05).
Regarding Ob-Ra mRNA expression no signiﬁcant differ-
ences were observed between normal, minimal and ad-
vanced OA cartilage, as well as between knee and hip
osteoarthritic cartilage (P> 0.05). Matched paired analysis
of the samples did not show any signiﬁcant difference be-
tween mild and severe damaged OA cartilage in the same
joint (P> 0.05).
When we compared leptin’s mRNA expression with its re-
ceptors mRNA expression levels, a positive correlation was
found only between leptin and Ob-Rb mRNA expression
(Pearson rank correlation r¼ 0.377, P< 0.05). Regarding
the radiological data of the patients, no signiﬁcant associa-
tion was observed between leptin, Ob-Rb or Ob-Ra mRNA
levels and the K/L score or the clinical data of the patients
(pain, swelling, stiffness, history of osteoporosis, history of
hypertension).
We also measured Ob-Rb mRNA expression in cultured
cells growing in the presence and absence of leptin. During
the experiment OA chondrocytes expressed Ob-Rb mRNA
in higher levels than normal chondrocytes. Leptin inhibited
Ob-Rb mRNA levels in normal chondrocytes, while no differ-
ence was detected in OA chondrocytes. In detail, concentra-
tions of 0.1e10 ng/ml of leptin did not affect Ob-Rb mRNA
expression; however, concentrations of 100 ng/ml of leptinwere able to suppress Ob-Rb mRNA levels (7.8-fold) in nor-
mal chondrocytes, while therewas no signiﬁcant effect of lep-
tin on Ob-Rb mRNA expression in OA chondrocytes (Fig. 4).
Regarding the effect of leptin on Ob-Ra mRNA expression
there was no signiﬁcant difference either in normal or in OA
chondrocytes.
LEPTIN AND LEPTIN RECEPTOR PROTEIN EXPRESSION
ON CHONDROCYTES AND CARTILAGE EXPLANTS
Leptin’s protein expression was evaluated by Western
blot analysis. It was observed that leptin protein levels
were very high in OA chondrocytes and very low in normal
cultured chondrocytes. There was also an increase in pro-
tein levels of the long-form of leptin receptor (Ob-Rb) in
OA chondrocytes (Fig. 5). The Western blot analysis of car-
tilage explants was able to reveal low expression of leptin
and Ob-Rb in the OA chondrocytes.
CORRELATION OF LEPTIN’S mRNA EXPRESSION WITH BMI
In order to investigate the role of obesity in OA, we catego-
rized our patients according to their BMI.We observed signif-
icantly different leptin mRNA expression levels, in weight
bearing regions, between obese and normal weight patients
(ANOVA,P< 0.05).More speciﬁcally, after post hoc analysis
with Tukey HSD test, we observed signiﬁcantly higher mean
leptin mRNA expression in obese patients (0.294 0.039
leptin copies/PBGD copies) compared to normal weight
878 T. Simopoulou et al.: Leptin’s expression in OA CartilageFig. 4. Leptin’s effect on mean Ob-Rb’s mRNA expression (Ob-Rb mRNA copies/PBGD copies) in cultured normal and osteoarthritic chon-
drocytes (0e7 days).patients (0.128 0.049 leptin copies/PBGD copies), while
there was no difference with the overweight group
(0.2 0.1 leptin copies/PBGDcopies) (Fig. 6). Similar results
were obtained when obesity was categorized according to
BMI tertiles. Participants in the middle and upper BMI tertiles
had signiﬁcantly higher leptin mRNA expression levels com-
pared to patients in the lower tertile and controls (ANOVA,
P< 0.05). Leptin’s mRNA expression levels in advanced
OA cartilage correlated signiﬁcantly with BMI values of the
patients (Pearson rank correlation r¼ 0.571, P< 0.05). Re-
garding Ob-Rb, there was no difference in the Ob-Rb
mRNA expression between normal weight, overweight and
obese patients, and also no correlation was found between
BMI values and Ob-Rb mRNA expression levels.
LEPTIN’S EFFECT ON CHONDROCYTE PROLIFERATION
Leptin enhanced the proliferation of normal chondrocytes
after 24 h and 48 h culture, but reduced the proliferation of
OA chondrocytes for the same culture period. After 72 h
and until 7 days culture with leptin, chondrocytes’ prolifera-
tion was decreased both in normal and OA chondrocytes
[Fig. 7(a, b)]. The experiment was performed three times
with similar results. In order to clarify whether leptin de-
creases chondrocyte proliferation or increases apoptosis,
or both we analyzed the apoptotic rate in cultures of human
chondrocytes; no apoptotic cells were detected after 7 days
while there was no difference regarding the proportion of liv-
ing cells incubated in the presence or absence of leptin.LEPTIN’S EFFECT ON IL-1b AND NO PRODUCTION
Leptin enhanced the production of the inﬂammatory cyto-
kine IL-1b in long term cultures. More speciﬁcally, normal
and osteoarthritic chondrocytes did not produce IL-1b for
24 h, 48 h and 72 h after stimulation with increasing con-
centrations of leptin (0e100 ng/ml). However, after 7 days
in culture, both normal and osteoarthritic chondrocytes pro-
duced IL-1b. In detail, in normal chondrocytes we found an
8.7-fold increase in IL-1b production after induction with
100 ng/ml of leptin. Regarding osteoarthritic chondrocytes
we observed a 4.5-fold increase in IL-1b production after
incubation with low leptin concentrations (1 ng/ml), which
remained quite constant even with high leptin concentra-
tions (100 ng/ml) (Fig. 8). Regarding NO production, there
was no detectable NO production in cultures stimulated
with leptin.
MMP-9, MMP-13 PROTEIN EXPRESSION IN OA AND NORMAL
CHONDROCYTES AFTER LEPTIN TREATMENT
We treated the osteoarthritic and normal chondrocytes for
5 and 7 days with increasing leptin concentrations (0, 0.1, 1,
10, 100 ng/ml) and determined MMP-9 and MMP-13 protein
levels. Concentrations of 0.1 and 1 ng/ml of leptin were not
able to induce MMP-9 and MMP-13 levels, while the highest
effect was found using 100 ng/ml leptin. In detail, MMP-9
and MMP-13 protein expression after treatment with
100 ng/ml leptin for 5 days was increased 1.8-fold andFig. 5. Leptin (a) and Ob-Rb (b) protein expression evaluated by Western blot analysis in normal and OA (mild and advanced) chondrocytes.
GAPDH protein levels were used as a loading control.
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tilage (leptin mRNA copies/PBGD copies) of all patients grouped
according to BMI. (*) P< 0.05 was considered signiﬁcant.1.9-fold in OA chondrocytes and 6.7-fold and 5.2-fold in nor-
mal chondrocytes, respectively, while after 7 days of treat-
ment with leptin in OA and normal chondrocytes we
detected an increase in protein expression of MMP-9 (2.4-
fold and 7.8-fold) and MMP-13 (2.8-fold and 5.4-fold), re-
spectively (Fig. 9).
SERUM AND SF LEPTIN LEVELS: CORRELATION
WITH ARTICULAR LEVELS
Our study revealed a signiﬁcant difference between se-
rum and SF leptin levels (P< 0.0005); leptin in the SF
was from 3 to 11 times higher than in paired serum sample.
Serum as well as SF leptin levels were signiﬁcantly higher
to women than men (P< 0.001). There was a signiﬁcant
correlation between serum and SF leptin levels (r¼ 0.709,
P< 0.01). Also, leptin levels in serum and SF showed a
signiﬁcant correlation with BMI (r¼ 0.489, P< 0.05 and
r¼ 0.620, P< 0.01, respectively), while no correlation was
found between serum and SF leptin levels and articular
levels of leptin and its receptor.Fig. 7. (a, b) Effect of leptin on cell proliferation of osteoarthritic and normal chondrocytes in 24 h (a) and 72 h (b) cultures. Cell number is
expressed as percentage of control; i.e., cell cultures that had no leptin. Data are shown as mean standard error of three independent ex-
periments. C, control; (*) P< 0.05 was considered signiﬁcant.
880 T. Simopoulou et al.: Leptin’s expression in OA CartilageFig. 8. Effect of increasing leptin concentrations (0e100 ng/ml) on IL-1b production by normal and osteoarthritic (OA) chondrocytes after
7 days culture.Discussion
The hypothesis that OA is a metabolic disease in which
systemic and/or local factors that include altered lipid metab-
olism induce changes in skeletal tissues could offer some ex-
planations for the diversity of structural and biochemical
changes present in OA40. Leptin appears to be an important
local and systemic factor inﬂuencing bone and cartilage ho-
meostasis. However, it has been suggested that locally
produced leptin may be more important than circulating
leptin in the regulation of bone metabolism as leptin
receptor expression has been demonstrated in human oste-
oblasts, leptin-induced osteoblasts proliferation, collagen
synthesis and bone mineralizaiton and leptin signaling has
been found to contribute to mechanisms of joint
inﬂammation24,41,42.
In order to investigate whether leptin has a local or a sys-
temic effect on cartilage, we quantiﬁed leptin in paired se-
rum and SF samples and observed signiﬁcantly elevated
leptin concentration levels in SF samples than in serum,
suggesting a local production of leptin rather than diffusion
from plasma to SF through the synovial membrane. Differ-
ential distribution of leptin between serum and SF has
been recently observed in patients with OA34.
The observation, in the present study, that chondrocytes
are capable of expressing leptin mRNA and protein also sug-
gests a local role of this adipocytokine. To investigate on the
role of leptin and its two major receptor isoforms, Ob-Rb and
Ob-Ra in OA process, we quantiﬁed, for the ﬁrst time to our
knowledge, leptin and its receptors mRNA expression using
an accurate and sensitive real-time RT-PCRmethod and we
also evaluated and quantiﬁed their protein expression. In ad-
dition, in order to investigate for intrajoint differences of leptin,
Ob-Rb and Ob-Ra mRNA expression, we used two different
types of cartilage from each patient; advanced OA cartilage
from the main defective area of maximal load and minimal
OA tissue from an adjacent macroscopically and histological
intact area. This type of approach provided the advantage of
control over confounding variables such as age, genetic
background, differences in clinical management, andartefacts due to specimen collection since the major compar-
isons aremade between cartilage samples from the same in-
dividual. Since minimally affected OA cartilage was obtained
from a joint that was clearly involved in a disease process we
assumed that it cannot be completely comparable to normal
cartilage; therefore non-OA cartilagewas also included in the
study. Our study revealed the presence of a considerable in-
crease of leptin as well as of Ob-Rb mRNA expression in OA
cartilage compared to normal tissue, as well as between se-
verely damaged and adjacent mildly affected OA cartilage.
Although leptin and Ob-Rb mRNA expression in normal
andmildly damaged OA cartilage was low, it was biologically
active and capable of promoting protein expression. The
observed intrajoint differences of leptin and Ob-Rb mRNA
expression may be the result of the different levels of leptin
reaching chondrocytes from the SF, depending on the grade
of cartilage destruction, ﬁssuring or damage of the extracellu-
larmatrix, which exerts a stimulatory effect on its own synthe-
sis by articular chondrocytes37. Overall, it can be suggested
that leptin and Ob-RbmRNA expression is induced in severe
cartilage destruction. Ob-Ra mRNA expression levels were
found to be similar between normal and OA cartilage, in con-
cordance with Ob-Ra’s reduced signaling transduction capa-
bility. As Ob-Ra may internalize or degrade leptin, the lack of
local differential expression of Ob-Ra between OA and nor-
mal cartilage suggests that cartilage is unlikely to be involved
in leptin’s clearance and that OA does not associate or inﬂu-
ence leptin’s clearance. To our knowledge, the existing rela-
tive reports have used only immunostaining methods for the
detection of leptin and/or Ob-Rb in human osteoarthritic car-
tilage27,43. Figenschau et al.33 cultured human adult articular
chondrocytes and found that they express the functional iso-
formof leptin receptor (Ob-Rb) and phosphorylation of STAT-
1 and STAT-5 in chondrocytes treated with recombinant
human leptin was demonstrated, providing a convincing
evidence for a direct action of leptin in these cells. In the pres-
ent study leptin and leptin receptor protein expression was
also observed in cultured articular chondrocytes. Based on
our real-time PCR results, there is a common ﬁnding of leptin







1 9.2 1 7.6
MMP9
GAPDH











0 5  7 days
leptin
0 5 7 days
leptin
1 6.7 7.8 1 5.2 5.4
Fig. 9. MMP-9 and MMP-13 protein expression in normal and osteoarthritic (OA) chondrocytes. (a) MMP-9 and MMP-13 protein levels are very
high in OA vs normal (N) chondrocytes. GAPDH expression levels were used as a loading control. (b) MMP-9 andMMP-13 protein expression in
OA chondrocytes after treatment with 100 ng/ml leptin for 5 and 7 days. MMP-9 andMMP-13 after leptin treatment are evenmore up-regulated in
OA chondrocytes. (c) MMP-9 and MMP-13 protein expression in normal chondrocytes after treatment with 100 ng/ml leptin for 5 and 7 days.and Ob-Rb mRNA expression in articular chondrocytes and
in cultured chondrocytes, suggesting that the in vitro data
may be extended to the in vivo situation.
In order to study the effect of leptin on theOb-RbmRNAwe
measuredmRNAexpression levels ofOb-Rb in cultured cells
growing in the presence and absence of leptin. During the ex-
periment a signiﬁcant decrease in Ob-Rb mRNA levels was
demonstrated in normal chondrocytes after treatment with
high leptin concentrations, suggesting that leptin itself may
act as an inhibitory regulator of its receptors expression. Hy-
perleptinemia observed in obesepeople hasbeenpostulated
to cause inhibitory regulation at the level of the leptin recep-
tors or the downstream of the signaling pathway; furthermore
leptin-induced inhibitory effects on its receptors expression
has been reported even in peripheral cells44.
After conﬁrming the expression of leptin and its receptors
in cartilage, we investigated the effect of leptin on cell pro-
liferation and apoptosis in normal and osteoarthritic cultured
chondrocytes. It has been demonstrated in short-term cul-
tures of normal chondrocytes, incubated with the additionof serum, a stimulatory effect of leptin on chondrocyte pro-
liferation33. Our study showed that leptin enhanced cell pro-
liferation in short-term cultures of normal chondrocytes,
however, in long term cultures this stimulatory effect was
lost. When chondrocytes were treated with increasing leptin
concentrations, their cell proliferation was decreased while
no increase was observed in their apoptosis rate compared
to the untreated cells, indicating a long term detrimental ef-
fect of leptin on cell viability and not on apoptosis. It has
been suggested that leptineleptin receptor axis is important
for cell proliferation in many tissues14,45e48.
As leptin has been directly associated with obesity, a
potent risk factor for knee OA development32, with regard
to increased mechanical load, we investigated the relation-
ship between leptin and its receptors mRNA expression,
knee and hip OA and obesity. We observed signiﬁcantly
increased leptin’s mRNA expression in obese compared to
normal weight patients, as well as a strong correlation
between leptin’s mRNA levels and the BMI of the patients.
In mildly damaged cartilage no correlation was found
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leptin’s overexpression in severely affectedOAcartilagemay
result frommechanical overload effects. At a cellular level ex-
cess load may manifest altered chondrocyte phenotype.
However, mechanical factors alone do not seem to be sufﬁ-
cient to explain the relationship between OA incidence and
obesity. The link between obesity and OA may involve com-
plex interactions of biomechanical and metabolic factors49.
Toassess apotential role of leptin on cartilagemetabolism,
we studied leptin’s direct effect on IL-1b and NO production
as well as on matrix metalloproteinases MMP-9 and MMP-
13 mRNA and protein expression in articular chondrocytes.
An induction of IL-1b production was observed after 7 days
culture period pointing toward a direct pro-inﬂammatory ef-
fect of leptin on chondrocytes. The pro-inﬂammatory role of
leptin has been previously documented in antigen-induced
arthritis, where leptin was found to regulate humoral and
cell-mediated immune responses24. Also, it has been ob-
served that leptin increases during acute inﬂammation, while
it is well established that obese individuals present elevated
levels of inﬂammation markers24, 25. We observed that leptin
hadnodirect effect on cultured chondrocytes’NOproduction.
Recent experimental evidence has pointed toward a syner-
gistic effect of leptin with IFN-g and IL-1b on NO synthase
type II activation in cultured chondrocytes via the activation
of JAK-2 kinase, PI-3 kinase, MEK-1 and p38 kinase22,23.
The above data reinforce the view that leptin acts as a pro-
inﬂammatory cytokine.
We also evaluated for the ﬁrst time to our knowledge
MMP-9 and MMP-13 mRNA and protein expression in oste-
oarthritic and normal chondrocytes after treatment with lep-
tin. MMP-9 and MMP-13 are among the major enzymes that
mediate the destructive process in OA and their immunocy-
tochemical localization and increased expression has been
conﬁrmed in OA cartilage50e53. We observed a leptin dose
dependent increase in MMP-13 and MMP-9 mRNA and pro-
tein expression in OA and normal chondrocytes, indicating
a catabolic role of leptin in cartilage metabolism.
Taken together our ﬁndings suggest that leptin is involved
in OA development and that may be the missing link be-
tween biomechanical and metabolic factors involved in
OA. The detection, in the present study, of leptin and its re-
ceptors mRNA and protein expression in OA articular chon-
drocytes indicates that this adipocytokine can indeed affect
cartilage metabolism directly. The observed intrajoint differ-
ence of leptin and its functional receptor expression be-
tween severely and mildly affected osteoarthritic cartilage
could indicate that leptin relates to the grade of cartilage
destruction. Furthermore, it can be suggested that in pa-
tients with OA there is a unique microenvironment in the
cartilage characterized by enhanced locally produced leptin
levels, which induce IL-1b and MMP-9 and MMP-13 produc-
tion by chondrocytes, reinforcing the scenario that leptin
acts as a pro-inﬂammatory cytokine with a catabolic role
on cartilage metabolism. However, further studies are re-
quired to elucidate on leptin’s catabolic role on cartilage
metabolism.
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